New AI paper from us this week. When my student first showed me his initial findings, I really didn’t know what to make of them. I felt that this was an interesting but curious loophole phenomenon that would shortly be closed. I was very wrong.
https://t.co/H3YIyl01FR
We are recruiting up to 5 Pandemic Sciences Research Fellows at @UniofOxford. Posts are for recent graduates to carry out independent research on topics in one or more of the following areas: AI & Epi, Genomics, Climate & Infectious diseases, Global health digital data science ↓
Today, we can announce a new industry-government partnership with up to £400 million of investment to support faster patient access to cutting-edge treatments, strengthen clinical trials, and improve UK medicine manufacturing.
Find out more: https://t.co/fhAa6h3wDL @DHSCgovuk@UK_Life_Science@SciTechgovuk
Delighted to be appointed Chair of Warwick Innovation at one of the most exciting times in history for science, technology and innovation.
Honoured to build on the huge achievements of Lord Bhattacharyya & colleagues’ work at @wmg, @uniofwarwick and beyond.
#IndustrialStrategy
Investing in health research capacity & skills will be critical for driving future innovations & partnerships, making the most of our health data, assets enabling improvements for patients, thus UK productivity & growth @profadmorris @emma_k_lowe @NIHRresearch@UK_Life_Science
🚨 New in @TheLancet: Academy President Professor Andrew Morris PMedSci calls on Government to prioritise NHS research as a catalyst for better health and economic growth.
He also outlines 5 key areas to strengthen UK health research. Read the article 👇
https://t.co/LMTySXWuE0
Big statement alert:
This is a LANDMARK in the history of clinical gene editing. This means we can dose to effect. This means we can sequentially edit targets. This means we can reverse certain edits.
Cue "A whole new wooorld..."
1/3 🧵
Ahead of the UK #GeneralElection2024, we are co-hosting a free science, innovation and technology hustings.
Hear directly from political party representatives, & ask them your questions on science policy.
Watch live from 6:30pm, Wednesday 19 June https://t.co/SOq4kW79Qq
Moderna can make 34 custom mRNAs on demand - GMP - IN TWO WEEKS to treat a person with cancer.
The same can be true for CRISPR Cures for a devastatingly ill infant who needs a custom gRNA to save their life.
Yes it can.
Watch this space.
@ewanbirney I remember a great 2x2 about keeping to the rules, and expecting others to. Eg British people expect others to keep to rules, but not themselves. Dutch keep the rules but completely don’t mind what others do.. Italy no one cares.. etc
Inspiring talk from Pearse Keane driving home that successful deployment of AI will require coordinated networks of innovation and robust business models @pearsekeane@HDR_UK